OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Paul Worley

2 Projects | 1 Researchers | $310,000 Invested

2021

Johns Hopkins University

Paul Worley, MD

Preserving NPTX2 and Memory in Alzheimer's Disease

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2018

Johns Hopkins University

Paul Worley, MD

Resilience Biomarker NPTX2 and AD Progression

  • Funding Amount: $160,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed